Table 3.

Outcomes at 30-Days

Outcome (%):	(a) Baseline SR / Discharge SR	(b) Baseline SR / Discharge AF	(c) Baseline AF / Discharge AF	p-value All Groups	p-value a vs. b	p-value a vs. c	p value b vs. c
Mortality
- All Cause	2.6	14.2	3.6	<0.0001	<0.001	0.27	<0.001
- Cardiovascular	1.6	8.3	2.8	<0.0001	<0.001	0.11	0.007
Rehospitalization	5.3	5.8	7.2	0.36
Stroke/TIA	3.9	7.4	3.2	0.16
Major Bleeding	7.3	9.9	7.9	0.58
Major Vascular Event	5.5	4.4	5.8	0.86
Renal Failure requiring dialysis	1.5	6.3	3.2	0.001	0.0003	0.02	0.13
New Pacemaker	5.2	12.7	5.1	0.004	0.001	0.96	0.004
LVEF	58.7 [50.0,63.4]	59.1 [54.9,62.6]	55.0 [49.2,60.0]	0.0001	0.78	<0.0001	0.02
Change in 6MTWD (mean in meters)	21.8	−4.2	12.1	0.07
Length of Stay in Hospital after TAVR (days)	6.0 [4.0,7.0]	7.0 [5.0,8.0]	7.0 [5.0,8.0]	0.0004	0.002	0.005	0.09
On Aspirin	89.6	85.3	84.2	0.008	0.19	0.003	0.80
On Clopidogrel	58.6	30.9	27.5	<0.0001	<0.0001	<0.0001	0.51